#apalutamide
Latest news and interesting information about apalutamide.
Prostate cancer death risk cut by 20% with J&J drug
Johnson & Johnson's apalutamide reduces prostate cancer death risk by 20%, according to Phase 3 trial results.
...
Latest news and interesting information about apalutamide.